Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 337 to 348 of 348 entries
Sorted by: Best Match Show Resources per page
Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma.

Oncotarget

Blayney JK, Cairns L, Li G, McCabe N, Stevenson L, Peters CJ, Reid NB, Spence VJ, Chisambo C, McManus D, James J, McQuaid S, Craig S, Arthur K, McArt D, Ong CJ, Lao-Sirieix P, Hamilton P, Salto-Tellez M, Eatock M, Coleman HG, Fitzgerald RC, Kennedy RD, Turkington RC.
PMID: 29719622
Oncotarget. 2018 Apr 06;9(26):18518-18528. doi: 10.18632/oncotarget.24906. eCollection 2018 Apr 06.

BACKGROUND: The current TNM staging system for oesophageal adenocarcinoma (OAC) has limited ability to stratify patients and inform clinical management following neo-adjuvant chemotherapy and surgery.RESULTS: Functional genomic analysis of the gene expression data using Gene Set Enrichment Analysis (GSEA)...

Cite
Blayney JK, Cairns L, Li G, et al. Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma. Oncotarget. 2018;9(26):18518-18528doi: 10.18632/oncotarget.24906.
Blayney, J. K., Cairns, L., Li, G., McCabe, N., Stevenson, L., Peters, C. J., Reid, N. B., Spence, V. J., Chisambo, C., McManus, D., James, J., McQuaid, S., Craig, S., Arthur, K., McArt, D., Ong, C. J., Lao-Sirieix, P., Hamilton, P., Salto-Tellez, M., Eatock, M., Coleman, H. G., Fitzgerald, R. C., Kennedy, R. D., Turkington, R. C. (2018). Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma. Oncotarget, 9(26), 18518-18528. https://doi.org/10.18632/oncotarget.24906
Blayney, Jaine K, et al. "Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma." Oncotarget vol. 9,26 (2018): 18518-18528. doi: https://doi.org/10.18632/oncotarget.24906
Blayney JK, Cairns L, Li G, McCabe N, Stevenson L, Peters CJ, Reid NB, Spence VJ, Chisambo C, McManus D, James J, McQuaid S, Craig S, Arthur K, McArt D, Ong CJ, Lao-Sirieix P, Hamilton P, Salto-Tellez M, Eatock M, Coleman HG, Fitzgerald RC, Kennedy RD, Turkington RC. Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma. Oncotarget. 2018 Apr 06;9(26):18518-18528. doi: 10.18632/oncotarget.24906. eCollection 2018 Apr 06. PMID: 29719622; PMCID: PMC5915089.
Copy Download .nbib Format: NLM
Re-Os isotopic evidence for long-lived heterogeneity and equilibration processes in the Earth's upper mantle.

Nature

Meibom A, Sleep NH, Chamberlain CP, Coleman RG, Frei R, Hren MT, Wooden JL.
PMID: 12384694
Nature. 2002 Oct 17;419(6908):705-8. doi: 10.1038/nature01067.

The geochemical composition of the Earth's upper mantle is thought to reflect 4.5 billion years of melt extraction, as well as the recycling of crustal materials. The fractionation of rhenium and osmium during partial melting in the upper mantle...

Cite
Meibom A, Sleep NH, Chamberlain CP, et al. Re-Os isotopic evidence for long-lived heterogeneity and equilibration processes in the Earth's upper mantle. Nature. 2002;419(6908):705-8doi: 10.1038/nature01067.
Meibom, A., Sleep, N. H., Chamberlain, C. P., Coleman, R. G., Frei, R., Hren, M. T., & Wooden, J. L. (2002). Re-Os isotopic evidence for long-lived heterogeneity and equilibration processes in the Earth's upper mantle. Nature, 419(6908), 705-8. https://doi.org/10.1038/nature01067
Meibom, Anders, et al. "Re-Os isotopic evidence for long-lived heterogeneity and equilibration processes in the Earth's upper mantle." Nature vol. 419,6908 (2002): 705-8. doi: https://doi.org/10.1038/nature01067
Meibom A, Sleep NH, Chamberlain CP, Coleman RG, Frei R, Hren MT, Wooden JL. Re-Os isotopic evidence for long-lived heterogeneity and equilibration processes in the Earth's upper mantle. Nature. 2002 Oct 17;419(6908):705-8. doi: 10.1038/nature01067. PMID: 12384694.
Copy Download .nbib Format: NLM
Plasma extracellular vesicles released after severe burn injury modulate macrophage phenotype and function.

Journal of leukocyte biology

Willis ML, Mahung C, Wallet SM, Barnett A, Cairns BA, Coleman LG, Maile R.
PMID: 34342045
J Leukoc Biol. 2022 Jan;111(1):33-49. doi: 10.1002/JLB.3MIA0321-150RR. Epub 2021 Aug 03.

Extracellular vesicles (EVs) have emerged as key regulators of immune function across multiple diseases. Severe burn injury is a devastating trauma with significant immune dysfunction that results in an ∼12% mortality rate due to sepsis-induced organ failure, pneumonia, and...

Cite
Willis ML, Mahung C, Wallet SM, et al. Plasma extracellular vesicles released after severe burn injury modulate macrophage phenotype and function. J Leukoc Biol. 2021;111(1):33-49doi: 10.1002/JLB.3MIA0321-150RR.
Willis, M. L., Mahung, C., Wallet, S. M., Barnett, A., Cairns, B. A., Coleman, L. G., & Maile, R. (2022). Plasma extracellular vesicles released after severe burn injury modulate macrophage phenotype and function. Journal of leukocyte biology, 111(1), 33-49. https://doi.org/10.1002/JLB.3MIA0321-150RR
Willis, Micah L, et al. "Plasma extracellular vesicles released after severe burn injury modulate macrophage phenotype and function." Journal of leukocyte biology vol. 111,1 (2022): 33-49. doi: https://doi.org/10.1002/JLB.3MIA0321-150RR
Willis ML, Mahung C, Wallet SM, Barnett A, Cairns BA, Coleman LG, Maile R. Plasma extracellular vesicles released after severe burn injury modulate macrophage phenotype and function. J Leukoc Biol. 2022 Jan;111(1):33-49. doi: 10.1002/JLB.3MIA0321-150RR. Epub 2021 Aug 03. PMID: 34342045.
Copy Download .nbib Format: NLM
Exploring C-To-G Base Editing in Rice, Tomato, and Poplar.

Frontiers in genome editing

Sretenovic S, Liu S, Li G, Cheng Y, Fan T, Xu Y, Zhou J, Zheng X, Coleman G, Zhang Y, Qi Y.
PMID: 34713268
Front Genome Ed. 2021 Sep 15;3:756766. doi: 10.3389/fgeed.2021.756766. eCollection 2021.

As a precise genome editing technology, base editing is broadly used in both basic and applied plant research. Cytosine base editors (CBEs) and adenine base editors (ABEs) represent the two commonly used base editor types that mediate C-to-T and...

Cite
Sretenovic S, Liu S, Li G, et al. Exploring C-To-G Base Editing in Rice, Tomato, and Poplar. Front Genome Ed. 2021;3:756766doi: 10.3389/fgeed.2021.756766.
Sretenovic, S., Liu, S., Li, G., Cheng, Y., Fan, T., Xu, Y., Zhou, J., Zheng, X., Coleman, G., Zhang, Y., & Qi, Y. (2021). Exploring C-To-G Base Editing in Rice, Tomato, and Poplar. Frontiers in genome editing, 3756766. https://doi.org/10.3389/fgeed.2021.756766
Sretenovic, Simon, et al. "Exploring C-To-G Base Editing in Rice, Tomato, and Poplar." Frontiers in genome editing vol. 3 (2021): 756766. doi: https://doi.org/10.3389/fgeed.2021.756766
Sretenovic S, Liu S, Li G, Cheng Y, Fan T, Xu Y, Zhou J, Zheng X, Coleman G, Zhang Y, Qi Y. Exploring C-To-G Base Editing in Rice, Tomato, and Poplar. Front Genome Ed. 2021 Sep 15;3:756766. doi: 10.3389/fgeed.2021.756766. eCollection 2021. PMID: 34713268; PMCID: PMC8525388.
Copy Download .nbib Format: NLM
Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections.

Diabetes technology & therapeutics

McAuley SA, Vogrin S, Lee MH, Paldus B, Trawley S, de Bock MI, Abraham MB, Bach LA, Burt MG, Cohen ND, Colman PG, Davis EA, Hendrieckx C, Holmes-Walker DJ, Jenkins AJ, Kaye J, Keech AC, Kumareswaran K, MacIsaac RJ, McCallum RW, Sims CM, Speight J, Stranks SN, Sundararajan V, Ward GM, Jones TW, O'Neal DN.
PMID: 33351699
Diabetes Technol Ther. 2021 Jun;23(6):460-466. doi: 10.1089/dia.2020.0589. Epub 2021 Jan 27.

No abstract available.

Cite
McAuley SA, Vogrin S, Lee MH, et al. Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections. Diabetes Technol Ther. 2021;23(6):460-466doi: 10.1089/dia.2020.0589.
McAuley, S. A., Vogrin, S., Lee, M. H., Paldus, B., Trawley, S., de Bock, M. I., Abraham, M. B., Bach, L. A., Burt, M. G., Cohen, N. D., Colman, P. G., Davis, E. A., Hendrieckx, C., Holmes-Walker, D. J., Jenkins, A. J., Kaye, J., Keech, A. C., Kumareswaran, K., MacIsaac, R. J., McCallum, R. W., Sims, C. M., Speight, J., Stranks, S. N., Sundararajan, V., Ward, G. M., Jones, T. W., O'Neal, D. N. (2021). Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections. Diabetes technology & therapeutics, 23(6), 460-466. https://doi.org/10.1089/dia.2020.0589
McAuley, Sybil A, et al. "Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections." Diabetes technology & therapeutics vol. 23,6 (2021): 460-466. doi: https://doi.org/10.1089/dia.2020.0589
McAuley SA, Vogrin S, Lee MH, Paldus B, Trawley S, de Bock MI, Abraham MB, Bach LA, Burt MG, Cohen ND, Colman PG, Davis EA, Hendrieckx C, Holmes-Walker DJ, Jenkins AJ, Kaye J, Keech AC, Kumareswaran K, MacIsaac RJ, McCallum RW, Sims CM, Speight J, Stranks SN, Sundararajan V, Ward GM, Jones TW, O'Neal DN. Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections. Diabetes Technol Ther. 2021 Jun;23(6):460-466. doi: 10.1089/dia.2020.0589. Epub 2021 Jan 27. PMID: 33351699.
Copy Download .nbib Format: NLM
The impact of the COVID-19 pandemic on endometrial cancer and endometrial hyperplasia diagnoses: a population-based study.

American journal of obstetrics and gynecology

Wylie J, Quinn D, Donnelly DW, McCluggage WG, Coleman HG, Gavin A, McMenamin ÚC.
PMID: 34971565
Am J Obstet Gynecol. 2021 Dec 29; doi: 10.1016/j.ajog.2021.12.259. Epub 2021 Dec 29.

No abstract available.

Cite
Wylie J, Quinn D, Donnelly DW, et al. The impact of the COVID-19 pandemic on endometrial cancer and endometrial hyperplasia diagnoses: a population-based study. Am J Obstet Gynecol. 2021;doi: 10.1016/j.ajog.2021.12.259.
Wylie, J., Quinn, D., Donnelly, D. W., McCluggage, W. G., Coleman, H. G., Gavin, A., & McMenamin, �. �. C. (2021). The impact of the COVID-19 pandemic on endometrial cancer and endometrial hyperplasia diagnoses: a population-based study. American journal of obstetrics and gynecology, . https://doi.org/10.1016/j.ajog.2021.12.259
Wylie, James, et al. "The impact of the COVID-19 pandemic on endometrial cancer and endometrial hyperplasia diagnoses: a population-based study." American journal of obstetrics and gynecology vol. (2021). doi: https://doi.org/10.1016/j.ajog.2021.12.259
Wylie J, Quinn D, Donnelly DW, McCluggage WG, Coleman HG, Gavin A, McMenamin ÚC. The impact of the COVID-19 pandemic on endometrial cancer and endometrial hyperplasia diagnoses: a population-based study. Am J Obstet Gynecol. 2021 Dec 29; doi: 10.1016/j.ajog.2021.12.259. Epub 2021 Dec 29. PMID: 34971565; PMCID: PMC8714241.
Copy Download .nbib Format: NLM
The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics.

Neural regeneration research

Coleman LG.
PMID: 34558528
Neural Regen Res. 2022 May;17(5):1020-1022. doi: 10.4103/1673-5374.324846.

No abstract available.

Cite
Coleman LG. The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics. Neural Regen Res. 2022;17(5):1020-1022doi: 10.4103/1673-5374.324846.
Coleman, L. G. (2022). The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics. Neural regeneration research, 17(5), 1020-1022. https://doi.org/10.4103/1673-5374.324846
Coleman, Leon G. "The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics." Neural regeneration research vol. 17,5 (2022): 1020-1022. doi: https://doi.org/10.4103/1673-5374.324846
Coleman LG. The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics. Neural Regen Res. 2022 May;17(5):1020-1022. doi: 10.4103/1673-5374.324846. PMID: 34558528; PMCID: PMC8552855.
Copy Download .nbib Format: NLM
A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes.

Diabetes care

Paldus B, Morrison D, Zaharieva DP, Lee MH, Jones H, Obeyesekere V, Lu J, Vogrin S, La Gerche A, McAuley SA, MacIsaac RJ, Jenkins AJ, Ward GM, Colman P, Smart CEM, Seckold R, King BR, Riddell MC, O'Neal DN.
PMID: 34789504
Diabetes Care. 2022 Jan 01;45(1):194-203. doi: 10.2337/dc21-1593.

OBJECTIVE: To compare glucose control with hybrid closed-loop (HCL) when challenged by high intensity exercise (HIE), moderate intensity exercise (MIE), and resistance exercise (RE) while profiling counterregulatory hormones, lactate, ketones, and kinetic data in adults with type 1 diabetes.RESEARCH...

Cite
Paldus B, Morrison D, Zaharieva DP, et al. A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes. Diabetes Care. 2022;45(1):194-203doi: 10.2337/dc21-1593.
Paldus, B., Morrison, D., Zaharieva, D. P., Lee, M. H., Jones, H., Obeyesekere, V., Lu, J., Vogrin, S., La Gerche, A., McAuley, S. A., MacIsaac, R. J., Jenkins, A. J., Ward, G. M., Colman, P., Smart, C. E. M., Seckold, R., King, B. R., Riddell, M. C., & O'Neal, D. N. (2022). A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes. Diabetes care, 45(1), 194-203. https://doi.org/10.2337/dc21-1593
Paldus, Barbora, et al. "A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes." Diabetes care vol. 45,1 (2022): 194-203. doi: https://doi.org/10.2337/dc21-1593
Paldus B, Morrison D, Zaharieva DP, Lee MH, Jones H, Obeyesekere V, Lu J, Vogrin S, La Gerche A, McAuley SA, MacIsaac RJ, Jenkins AJ, Ward GM, Colman P, Smart CEM, Seckold R, King BR, Riddell MC, O'Neal DN. A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes. Diabetes Care. 2022 Jan 01;45(1):194-203. doi: 10.2337/dc21-1593. PMID: 34789504.
Copy Download .nbib Format: NLM
Thromboinflammation Model-on-A-Chip by Whole Blood Microfluidics on Fixed Human Endothelium.

Diagnostics (Basel, Switzerland)

Dupuy A, Hagimola L, Mgaieth NSA, Houlahan CB, Preketes-Tardiani RE, Coleman PR, Passam FH.
PMID: 33573079
Diagnostics (Basel). 2021 Jan 29;11(2). doi: 10.3390/diagnostics11020203.

Microfluidic devices have an established role in the study of platelets and coagulation factors in thrombosis, with potential diagnostic applications. However, few microfluidic devices have assessed the contribution of neutrophils to thrombus formation, despite increasing knowledge of neutrophils' importance...

Cite
Dupuy A, Hagimola L, Mgaieth NSA, et al. Thromboinflammation Model-on-A-Chip by Whole Blood Microfluidics on Fixed Human Endothelium. Diagnostics (Basel). 2021;11(2)doi: 10.3390/diagnostics11020203.
Dupuy, A., Hagimola, L., Mgaieth, N. S. A., Houlahan, C. B., Preketes-Tardiani, R. E., Coleman, P. R., & Passam, F. H. (2021). Thromboinflammation Model-on-A-Chip by Whole Blood Microfluidics on Fixed Human Endothelium. Diagnostics (Basel, Switzerland), 11(2), . https://doi.org/10.3390/diagnostics11020203
Dupuy, Alexander, et al. "Thromboinflammation Model-on-A-Chip by Whole Blood Microfluidics on Fixed Human Endothelium." Diagnostics (Basel, Switzerland) vol. 11,2 (2021). doi: https://doi.org/10.3390/diagnostics11020203
Dupuy A, Hagimola L, Mgaieth NSA, Houlahan CB, Preketes-Tardiani RE, Coleman PR, Passam FH. Thromboinflammation Model-on-A-Chip by Whole Blood Microfluidics on Fixed Human Endothelium. Diagnostics (Basel). 2021 Jan 29;11(2). doi: 10.3390/diagnostics11020203. PMID: 33573079; PMCID: PMC7911484.
Copy Download .nbib Format: NLM
How to live in peace? Mapping the science of sustaining peace: A progress report.

The American psychologist

Coleman PT, Fisher J, Fry DP, Liebovitch LS, Chen-Carrel A, Souillac G.
PMID: 33180535
Am Psychol. 2021 Oct;76(7):1113-1127. doi: 10.1037/amp0000745. Epub 2020 Nov 12.

Despite good faith attempts by countless citizens, civil society, governments, and the international community, living in a sustainably peaceful community continues to be an elusive dream in much of our world. Among the challenges to sustaining peace is the...

Cite
Coleman PT, Fisher J, Fry DP, et al. How to live in peace? Mapping the science of sustaining peace: A progress report. Am Psychol. 2020;76(7):1113-1127doi: 10.1037/amp0000745.
Coleman, P. T., Fisher, J., Fry, D. P., Liebovitch, L. S., Chen-Carrel, A., & Souillac, G. (2021). How to live in peace? Mapping the science of sustaining peace: A progress report. The American psychologist, 76(7), 1113-1127. https://doi.org/10.1037/amp0000745
Coleman, Peter T, et al. "How to live in peace? Mapping the science of sustaining peace: A progress report." The American psychologist vol. 76,7 (2021): 1113-1127. doi: https://doi.org/10.1037/amp0000745
Coleman PT, Fisher J, Fry DP, Liebovitch LS, Chen-Carrel A, Souillac G. How to live in peace? Mapping the science of sustaining peace: A progress report. Am Psychol. 2021 Oct;76(7):1113-1127. doi: 10.1037/amp0000745. Epub 2020 Nov 12. PMID: 33180535.
Copy Download .nbib Format: NLM
Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial.

Diabetes care

McAuley SA, Trawley S, Vogrin S, Ward GM, Fourlanos S, A Grills C, Lee MH, Alipoor AM, O'Neal DN, O'Regan NA, Sundararajan V, Colman PG, MacIsaac RJ.
PMID: 34844995
Diabetes Care. 2021 Nov 29; doi: 10.2337/dc21-1667. Epub 2021 Nov 29.

OBJECTIVE: To assess the efficacy and safety of closed-loop insulin delivery compared with sensor-augmented pump therapy among older adults with type 1 diabetes.RESEARCH DESIGN AND METHODS: This open-label, randomized (1:1), crossover trial compared 4 months of closed-loop versus sensor-augmented...

Cite
McAuley SA, Trawley S, Vogrin S, et al. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. Diabetes Care. 2021;doi: 10.2337/dc21-1667.
McAuley, S. A., Trawley, S., Vogrin, S., Ward, G. M., Fourlanos, S., A Grills, C., Lee, M. H., Alipoor, A. M., O'Neal, D. N., O'Regan, N. A., Sundararajan, V., Colman, P. G., & MacIsaac, R. J. (2021). Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. Diabetes care, . https://doi.org/10.2337/dc21-1667
McAuley, Sybil A, et al. "Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial." Diabetes care vol. (2021). doi: https://doi.org/10.2337/dc21-1667
McAuley SA, Trawley S, Vogrin S, Ward GM, Fourlanos S, A Grills C, Lee MH, Alipoor AM, O'Neal DN, O'Regan NA, Sundararajan V, Colman PG, MacIsaac RJ. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. Diabetes Care. 2021 Nov 29; doi: 10.2337/dc21-1667. Epub 2021 Nov 29. PMID: 34844995.
Copy Download .nbib Format: NLM
The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics.

Neural regeneration research

Coleman LG.
PMID: 34558528
Neural Regen Res. 2022 May;17(5):1020-1022. doi: 10.4103/1673-5374.324846.

No abstract available.

Cite
Coleman LG. The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics. Neural Regen Res. 2022;17(5):1020-1022doi: 10.4103/1673-5374.324846.
Coleman, L. G. (2022). The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics. Neural regeneration research, 17(5), 1020-1022. https://doi.org/10.4103/1673-5374.324846
Coleman, Leon G. "The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics." Neural regeneration research vol. 17,5 (2022): 1020-1022. doi: https://doi.org/10.4103/1673-5374.324846
Coleman LG. The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics. Neural Regen Res. 2022 May;17(5):1020-1022. doi: 10.4103/1673-5374.324846. PMID: 34558528; PMCID: PMC8552855.
Copy Download .nbib Format: NLM
Showing 337 to 348 of 348 entries